TY - JOUR
T1 - New therapies for type 2 diabetes based on glucagon-like peptide 1
AU - Salehi, Marzieh
AU - D'Alessio, David A.
PY - 2006/4
Y1 - 2006/4
N2 - Cells in the gastrointestinal tract secrete several hormones that stimulate insulin secretion, one of which is glucagon-like peptide (GLP-1). Several new drugs act through the GLP-1 signaling system to stimulate insulin release and regulate blood glucose levels in patients with diabetes. One such compound, exenatide (Byetta), has recently become available, and others are in clinical development.
AB - Cells in the gastrointestinal tract secrete several hormones that stimulate insulin secretion, one of which is glucagon-like peptide (GLP-1). Several new drugs act through the GLP-1 signaling system to stimulate insulin release and regulate blood glucose levels in patients with diabetes. One such compound, exenatide (Byetta), has recently become available, and others are in clinical development.
UR - http://www.scopus.com/inward/record.url?scp=33646107627&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646107627&partnerID=8YFLogxK
U2 - 10.3949/ccjm.73.4.382
DO - 10.3949/ccjm.73.4.382
M3 - Article
C2 - 16610399
AN - SCOPUS:33646107627
SN - 0891-1150
VL - 73
SP - 382
EP - 389
JO - Cleveland Clinic journal of medicine
JF - Cleveland Clinic journal of medicine
IS - 4
ER -